Insight Molecular Diagnostics Inc. (IMDX)
NASDAQ · Manufacturing · In vitro & in vivo diagnostic substances
IMDX price, last 12 months
Key stats
- Previous close
- $1.59
- Open
- $1.64
- Day range
- $1.60 – $1.80
- 52-week range
- $1.50 – $7.51
- Volume
- 170.4K
- Avg volume (20 days)
- 215.9K
- Market cap
- $70.0M
Performance
Technicals and fundamentals
About Insight Molecular Diagnostics Inc.
Insight Molecular Diagnostics Inc is a pioneering diagnostics technology company whose mission is to democratize access to novel molecular diagnostic testing to improve patient outcomes. The Company's flagship technology quantifies a molecular biomarker known as donor-derived cell-free DNA (dd-cfDNA). It is also in the process of rebranding its RUO test kit, GraftAssure, as GraftAssureIQ, and rebranding its future in-vitro diagnostic (IVD) test kit as GraftAssureDx. The company geographically operates in the United States, the United Kingdom, Europe, and the Asia-Pacific regions, with maximum revenue generated from the USA.
- Sector
- Manufacturing
- Industry
- In vitro & in vivo diagnostic substances
- Listed on
- NASDAQ
- Market cap
- $70.0M